Compliance barriers in glaucoma: a systematic classification. - Wikidata - awgldk - TriplyDB

Compliance barriers in glaucoma: a systematic classification.

Compliance barriers in glaucoma: a systematic classification.

http://www.wikidata.org/entity/Q48721186

about

Interventions for improving adherence to ocular hypotensive therapy Interventions for improving adherence to ocular hypotensive therapy Quality of Life in Glaucoma: A Review of the Literature How 'Drug Aware' are our Glaucoma Patients?Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey Medical Management of Glaucoma in the 21st Century from a Canadian Perspective Critical evaluation of latanoprostene bunod in the treatment of glaucoma Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency.Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ) in glaucoma using a qualitative study Predictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combination An exploratory study of factors influencing glaucoma treatment adherence Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study.An objective assessment of the variability in number of drops per bottle of glaucoma medication.Glaucoma patients' trust in the physician Adjunctive therapy patterns in glaucoma patients using prostaglandin analogs.Prevalence of self-reported early glaucoma eye drop bottle exhaustion and associated risk factors: a patient survey Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.Factors associated with adherence to glaucoma pharmacotherapy in the primary care setting Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice.Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure.The effect of medical therapy on IOP control in Ghana Predictors of adherence to glaucoma treatment in a multisite study.Travoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy.Determinants of medication adherence to topical glaucoma therapy.Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma Glaucoma patient expression of medication problems and nonadherence.The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.Impact of the introduction of generic latanoprost on glaucoma medication adherence.Accuracy of Patient-reported Adherence to Glaucoma Medications on a Visual Analog Scale Compared With Electronic Monitors Current and emerging medical therapies for glaucoma.Attributes Associated with Adherence to Glaucoma Medical Therapy and its Effects on Glaucoma Outcomes: An Evidence-Based Review and Potential Strategies to Improve Adherence.Health coaching for glaucoma care: a pilot study using mixed methods.Exploring the influence of patient-provider communication on intraocular pressure in glaucoma patients.Adherence to ocular hypotensive therapy: patient health education needs and views on group education Why Patients With Glaucoma Lose Vision: The Patient Perspective.Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/timolol among patients with open-angle glaucoma or ocular hypertension

P2860

Q24197680-E591AA46-74E0-445D-A824-CB3E832D5577 Q24241641-FA3F393B-A027-4F0F-88A9-8FE8E4F34BEF Q26747891-61E9AFBE-53B8-4527-ADB7-6F3D04A566BB Q26753173-916AE29A-4B2F-4FF4-91CC-6BC0EAC2B8DA Q26830201-1E6BD66A-D07E-411A-AB6D-E9F15D881C7D Q27304716-5372FFB1-CF20-4E8A-B70E-31DB67C4444C Q28074316-D6130406-8540-41F4-A11C-3B009A2B0D5F Q28077208-8F5CC91B-2230-41D9-9568-68E7FEA64F44 Q30890274-45A84817-FB08-4A62-8697-31F4B139800F Q33293442-1E00997C-910A-452C-A800-C938119B5F3D Q33546682-4B31A3BF-467C-475D-800E-431AEEEAC5DF Q33597692-2B76CE63-886E-41B7-9375-F29C68621ECE Q33687798-01EC86BF-73E7-48FA-B6B7-27A930811679 Q33717101-63C8B010-2906-4C23-874E-C0E7C31742C2 Q33720403-248834BE-06DE-4CA8-9F55-8E19DF95FD91 Q33769480-603157FB-F6A1-4895-A4E2-79A0BAE2CCB0 Q33812135-08AECAE4-7635-4193-9D0D-8B0FFA6BD164 Q33857744-E9B6C2B1-FE61-4DFC-BDFD-A903E7AD3E3E Q33931543-0888B43F-CF4D-411A-963B-B2B73255BABD Q34090075-B04D24C9-D63D-45C3-9E9F-BAB524BF8360 Q34357225-8229CD7E-AABA-4013-A806-F2EA64086364 Q34729093-C69A1BB6-9E44-4E67-99A4-FFBC87C0AF8A Q34953629-B6120AB0-143D-40F4-B8B4-CB814EFA9923 Q35104629-80B6FBB5-B709-4C6A-B26E-0050A5E6E1C0 Q35108156-B6E8CDB7-6748-46B7-9DF2-E3F3D1AE63BC Q35227003-AE5F9C4D-F4C4-485E-A759-BB6D881842BD Q35243409-F83A9C4C-AC76-4877-BDCE-7049C177B95F Q35500843-8C3CF9CD-2810-4335-9BE3-4C142D092E8E Q35537191-C738DC7A-943B-4349-95D9-A26E47955168 Q35571666-8D189E95-F8AD-4FD1-A82E-0094F756C13A Q35681331-1E67B430-F77D-404A-8244-4051B0DA38AB Q35899865-207A5FC7-EF45-4981-B0F4-93110B0DE957 Q36055050-272FED77-33B8-4ECA-BE76-13BA5AAB0EDF Q36066033-54F67267-3892-4682-89A8-730A006D14F3 Q36177075-2E351AAB-B4C9-4284-8344-9F9AE693FB82 Q36239996-A7EA87D4-FC72-4443-87B5-B48926F0069A Q36437242-1C87E18C-4E30-4868-89E8-0E4B6BD4BFB3 Q36557239-2677C7FE-C297-41AD-98B2-BDD3214D732A Q36626069-C38A13C3-BD68-4827-8967-C5F904C80175 Q36627716-B27B3A1B-DADE-417A-945F-1270C8EA3B1B

P2860

Compliance barriers in glaucoma: a systematic classification.

http://www.wikidata.org/entity/Q48721186

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Compliance barriers in glaucoma: a systematic classification.

@en

Compliance barriers in glaucoma: a systematic classification.

@nl

type

label

Compliance barriers in glaucoma: a systematic classification.

@en

Compliance barriers in glaucoma: a systematic classification.

@nl

prefLabel

Compliance barriers in glaucoma: a systematic classification.

@en

Compliance barriers in glaucoma: a systematic classification.

@nl

P1433

Q48721186-573ED7D0-4B3A-49BB-909C-B9FCA6CEDF1E

P1476

Q48721186-9C8D9861-AFA9-44AF-A658-65FED7883819

P2093

Q48721186-1101D92C-F772-4419-8E02-A465688A5A1A

Q48721186-59A6282F-B0F4-4C85-BCC2-5F1D4F1352C8

Q48721186-8C2D069B-8345-4508-8CE0-6D2FE54FC49B

Q48721186-C11506E8-3695-462A-8EAA-2C199659E183

Q48721186-D9F6767D-D069-47D0-ABB3-AE24787A29EE

P304

Q48721186-D52B641A-F3EF-4550-905B-D6A791D77E70

P31

Q48721186-317C93FE-3DC4-48DD-8368-3519F23C8673

P356

Q48721186-ABDE62DA-A223-4208-B488-7BA7C3C12B2B

P433

Q48721186-0B67F630-1425-42C5-A0AA-4A60B1362FA4

P478

Q48721186-4299C3C4-8FDA-47FE-8C10-F77CE5CACAFC

P577

Q48721186-06BF72D5-D63C-4433-A935-1EEE51EDA5DD

P698

Q48721186-C897CA92-54BC-459C-8CE6-989E638F1A1C

P356

00061198-200310000-00001

P1433

Journal of Glaucoma

P1476

Compliance barriers in glaucoma: a systematic classification.

@en

P2093

Cori A McClure

http://www.w3.org/2001/XMLSchema#string

David G Schlundt

http://www.w3.org/2001/XMLSchema#string

James C Tsai

http://www.w3.org/2001/XMLSchema#string

James W Pichert

http://www.w3.org/2001/XMLSchema#string

Sarah E Ramos

http://www.w3.org/2001/XMLSchema#string

P304

393-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00061198-200310000-00001

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14520147

http://www.w3.org/2001/XMLSchema#string